Clinical Trial Update: Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of oral tafamidis in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin-related Cardiomyopathy

Drugs mentioned

• Tafamidis (tafamidis)

Snippet

Sponsor: Pfizer | Conditions: TTR Cardiomyopathy | Phase 1 | Status: COMPLETED